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Abstract 
The kinetics of the complex formation between bovine cathepsin S and bovine stefin B was studied by conventional and stopped-flow techniques. 
The inhibition at low inhibitor concentrations was tight and reversible (k,,, = 5.8 x 10’ M-’ s-l, kdlrr = 4.9 x 10m4 s-’ at pH 6.0 and 25”C), whereas 
at higher inhibitor concentrations it was pseudo-irreversible (k,,, = 6.14 x 10’ M-’ SC’). The complex was formed directly lacking the fast pre- 
equilibrium step with the dissociation equilibrium constant of - 8 pM. The competitive nature of inhibition was confirmed. The k,, was found to 
be pH-Independent between pH 6.0 and 7.5 and decreased at lower or higher pH values in a way that strongly suggests involvement of two ionizable 
groups in the interaction (pK, = 5.2, pKz = 8.3). The enzyme-substrate interaction seems to be influenced by different ionizable groups (pK, = 4.4, 
pK, = 7.8). 
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1. Introduction 
Stefin B is a protein inhibitor of cysteine proteinases 
with M, of about 11,000 [1,2]. It was first isolated from 
rat liver [3] and later also from human [46] and bovine 
origin [7]. The latter was found to be the first mammalian 
member of the stefin family, where highly conserved 
QVVAG region was replaced with the QLVAG sequence 
[S] without any effect on its inhibitory activity [7,9]. The 
inhibitor forms a tight, equimolar complex with cysteine 
proteinases [lo] like other cystatins [l 11. Among them 
cathepsin B is inhibited with the lowest affinity [5,9]. The 
crystal structure of recombinant human stefin B in the 
complex with carboxymethylated papain [lo] confirmed 
the proposed mechanism of interaction of cysteine pro- 
teinases and their inhibitors from the cystatin superfa- 
mily [12], which differs from the classical one. Recently, 
stefin B was found to be able to inhibit cathepsin L at 
neutral pH, demonstrating its potential physiological 
role also at neutral conditions [13]. 
Cathepsin S is a lysosomal cysteine proteinase from 
papain family [14]. Like other lysosomal cathepsins, this 
enzyme is believed to be involved in intracellular protein 
turnover [ 151. It has been isolated as a single chain pro- 
tein with M, around 24,000 from various mammalian 
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trans-2,3-epoxypropyI-leucylamido-(3-guanidino)butane; -AMC4meth- 
yl-7-coumarylamide; Z-, benzyloxycarbonyl-. 
tissues [l&19]. For a long time it was confused with 
cathepsin L, although both enzymes significantly differ 
in their pH stability [13,20]. Finally, the amino acid se- 
quence of both enzymes from bovine origin clearly 
showed that these are two different enzymes [21,22]. The 
activity of papain-like cysteine proteinases is generally 
believed to be controlled by their protein inhibitors from 
the cystatin superfamily [1,2]. Some inhibitory kinetics of 
cathepsin S by stefin B has already been reported [23]. 
Although interactions between plant cysteine pro- 
teinases and cystatins have been extensively studied 
[24,25], no such data are available for mammalian pa- 
pain-like cysteine proteinases. In this study we have in- 
vestigated in more details the interaction between two 
mammalian proteins, bovine cathepsin S and bovine ste- 
fin B, with the aim to characterize the mechanism of their 
interaction, and to evaluate the potential physiological 
role of stefin B as an inhibitor of cathepsin S. 
2. Materials and methods 
2.1. Materials 
Z-Phe-Arg-AMC and dithiothreitol were purchased from Serva (Hei- 
delberg, Germany), dimethvlsulfoxide was from Merck (Darmstadt. 
Germ&y). Stocksblution oi the substrate was made in dim&hylsulfox: 
ide. Ep-475 was from Peptide Research Institute (Osaka, Japan); 
EDTA and papain (EC 3.4.22.2; 2x crystallized) were from Sigma (St. 
Louis, USA). Bovine cathepsin S [19] and bovine stefin B [7] were 
purified using published procedures. Cathepsin S (EC 3.4.22.27) and 
additionally purified papain [26] were active-site titrated with Ep-475 
as described previously [9], whereas tefin B was titrated with active-site 
titrated papain. Protein concentrations were determmed using the 
method of Lowry et al. [271. The papain concentration was determined 
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using an absorption coefficient of 2.39 1 g-’ cm-’ [28] and M, 23.400 
[29]. All other chemicals were of analytical grade. Unless otherwise 
stated, the kinetic experiments were done in phosphate buffer (100 mM 
Na2HP0.,/KH2P0, 50 mM NaCl. I mM EDTA) pH 6.0 and at 25°C. 
The following buffers were also used, when the pH was varied: 100 mM 
citrate buffer at pH 3.5 and 4.0, 100 mM acetate buffer at pH 4.5-5.5. 
100 mM phosphate buffer at pH 6.0-7.5, 100 mM Hepes at pH 8.0 and 
100 mM Tris-at pH 8.5. All-the buffers contained also 50.mM NaCl 
and 1 mM EDTA. The activating buffer for all the exoerlments was 3 
mM EDTA, containing 8 mM dzhiothreitol, pH 6.0. bimethylsulfox- 
Ide concentration was less than 3% throughout. 
2.2. Kinetics of the inhibition of cuthepsm S by steJin B 
The inhibition of cathepsin S by stefin B m the presence of Z-Phe- 
Arg-AMC was followed at excitation and emission wavelengths 370 
and 460 nm, respectively, using a Perkin Elmer LS3 spectrofluorimeter 
(USA), as described previously [9]. Fluorlmeter was on-line connected 
with an IBM XT computer. and Flusys program [30] was used for 
fluorimeter control. 
Faster reactions were monitored with a DX 17MV stopped-flow 
apparatus (Applied Photophysics, UK). The emission of released prod- 
uct was observed at an excitation wavelength of 360 nm through the 
cut-off filter with - 50% transmission at 400 nm. One syringe was filled 
with buffer and stefin B + substrate, whereas the second was filled with 
preactivated cathepsin S (5 min in the activation buffer). A 1O:l volume 
ratio of mixing was used in all the experiments. Stopped-flow traces 
were digitized and stored in an Archimedes computer. The stored pro- 
gress curves were composed of 400 data pairs (fluorescence. time). All 
kinetic constants obtained are averages of 6-10 individual runs. 
All the experiments were done under pseudo-first-order conditions 
with a lo-fold molar excess of stefin B over cathepsin S, and with less 
than 3% of substrate hydrolysis. 
2.3. Determination of k,, und K, 
The pH dependence of kinetic parameters for cathepsm S-catalysed 
Z-Phe-Arg-AMC hydrolysis was studied in the pH range 3.5-8.0. Sub- 
strate (various concentration) was dissolved in 1.95 ml of appropriate 
buffer. The reaction was started by the addition of 50 ml of preactivated 
cathepsin S (0.05-0.5 nM final concentration, depending on pH), which 
was found to be stable during the experiment. Initial velocltles of the 
cathepsin S-catalysed substrate hydrolysis were then measured m a 
Perkm Elmer LS3 spectrofluorimeter (USA) at excitation and emission 
wavelengths 370 and 460 nm, respectively. Seven to ten different sub- 
strate concentrations were used at each pH value. Double reciprocal 
plots showed that the kinetics adhered to the Michaelis-Menten model 
and also provided initial estimates of k,,, and K,,,. The refined kinetic 
parameters k,,, and K,,, were then determined by nonlinear regression 
analysis. 
3. Results 
3.1. Inhibition kinetics 
The tight-binding inhibition of cathepsin S by stefin B 
was studied in the presence of substrate. For their inter- 
action we assumed a simple, competitive mechanism of 





where k,,, is the second-order rate constant of complex 
formation and kdlss i the rate constant of its decomposi- 
tion. The release of product was recorded after mixing 
of enzyme with inhibitor + substrate in order to de- 
termine the kinetic constants. Progress curves obtained 
at low inhibitor concentrations (0. l-l .5 nM) were bipha- 
sic and could be best fitted to the following integrated 
equation [3 11: 
[P] = v,t + (v, - v,)( 1 - eek’)/k (1) 
where [P] presents the product concentration, and v, and 
v, are the initial and steady-state velocities, respectively. 
In this equation k is the apparent pseudo-first-order rate 
constant for the approach to steady state and is given by 
the following relationships [31]: 
k = kssL141 + [WL) + kc,,r\ (2) 
The pseudo-first-order rate constant k was found to 
increase linearly with increasing concentration of stefin 
B and a k,,, value of (5.8 ? 1 .O) x lo7 M-’ SC’ was calcu- 
lated from the slope of the plot (data not shown). The 
dissociation rate constant kdlss was calculated using the 
following equation [3 11: 
kdlas = k x v,/v, (3) 
All kdlss values obtained in this way from individual 
measurements were very close, giving an average value 
of (4.9 * 0.5) x 1o-J s-‘. 
It is possible that the stable EI complex is not formed 
directly (Scheme I) but through the fast pre-equilibrium 
as it is illustrated on Scheme II: 
E+S& ES+E+P 
I 
k bra dSS It 
k 
EI “, EI* 
k-1 
The apparent first-order rate constant k of Eqn. 1 is 
here given by the following equation [31]: 
k = k+,W([LI + K,(l + BJK,,)) + k-, (4) 
In an attempt to detect the intermediate (EI) the inhi- 
bition of cathepsin S by stefin B was also studied at high 
inhibitor concentrations ([I,] = 0.2-8.0 PM) at 20 PM Z- 
Phe-Arg-AMC with a stopped-flow apparatus. Progress 
curves obtained were analysed by nonlinear regression 
analysis and could be best fitted to single exponentials 
at all concentrations of stefin B investigated (Fig. l), 
indicating that the interaction is pseudo-irreversible 
(k,,,[I,] >> kdlSb). The fluorescence amplitude corre- 
sponding to the amount of product formed was constant 
at all inhibitor concentrations, indicating that the equi- 
librium between E and ES is established rapidly in com- 
parison to the equilibrium between E and EI. Similarly 
like at low inhibitor concentrations, pseudo-first-order 
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Fig. 1. Progress curve for the inhibition of cathepsin S by stefin B at 
25°C and pH 6.0. The reaction medium contained 500 nM stefin B, 50 
nM cathepsin S and 20 PM Z-Phe-Arg-AMC. The solid line crossing 
the stopped-flow trace is the theoretical curve generated using the best 
estimates of k and the intercept. 
rate constant k, increased linearly with increasing con- 
centration of stefin B up to the highest concentration 
investigated (Fig. 2), thus indicating that the proposed 
mechanism (Scheme I) is obeyed. Scheme II predicts a 
hyperbolic dependence of k upon [IO]. The slope of the 
regression line gave an association rate constant of 
(6.14 It: 0.11) x 10’ M-’ * s-‘, while the intercept of the 
line on the ordinate was indistinguishable from zero. 
This value is in good agreement with that determined at 
low reactant concentration, namely 5.8 x 10’ M-’ * s-‘. 
From both association and dissociation rate constants 
the equilibrium constant K, (= k&k,,) of (8.0 + 0.9) pM 
was calculated for the interaction at pH 6.0 and 25°C. 
The interaction was also investigated at different sub- 
strate concentration with [I,] = 500 nM and [E,] = 50 
nM, and k was plotted as a function of l/(1 + [S,]/K,) 
as can be seen in inset of Fig. 2. The linearity of the plot 
is in agreement with other experiments thus indicating 
lack of the fast pre-equilibrium (Scheme I). Similarly as 
for the dependence on inhibitor concentration Scheme II 
also predicts a hyperbolic dependence of k upon 
( 1 + [$,]I&,) (see Eqn. 4). The decrease of k with [S,] also 
provides evidence for the assumed competitive nature of 
the inhibition (Scheme I). The k,,, value calculated from 
the slope of this line (6.6 x lo7 M-’ ’ SC’) was also in good 
agreement with those obtained at low and high inhibitor 
concentrations, whereas the intercept on the ordinate 
was indistinguishable from zero, thus precluding the de- 
termination of kdlss (i.e. k,,,[I,] >> kd,J. 
3.2. pH-dependence of inhibition 
The pH-dependence of the association rate of stefin B 
with cathepsin S was studied with the stop~d-flow appa- 
ratus at 25°C under pseudo-first-order-conditions (Fig. 
3A). All the curves except at pH 3.5 reached a plateau, 
indicating that the effect of the complex dissociation 
under the conditions used in the experiments is negligi- 
ble, whereas at pH 3.5 practically no inhibition was ob- 
served. The association rate constant increased steeply 
from pH 4.0-6.0 and remained practically constant up 
to pH 7.5. Above this value a steep decrease was ob- 
served. The profile of the pH-dependence of k,,, suggests, 
that at least two ionizable groups are involved in the 
interaction. The data were fitted to the following equa- 
tion: 
k,, = kass(,,mj /( 1 + [H+]IK, + K,/[H+]) (5) 
where k asst,,m, presents the limiting value of k,,,. The two 
groups were compatible with involvement of an unpro- 
tonated acid group with piu, 5.2 5 0.1 and of a pro- 
tonated basic group with pKa 8.3 2 0.1. Also the pH- 
dependence of k,,/K,,,, the second-order ate constant for 
the reaction between the enzyme and the substrate was 
bell-shaped, indicating the influence of two ionizable 
groups on the substrate hydrolysis (Fig. 3b). When the 
data were fitted to the following equation: 
UK,,, = tk~~/k~)~,,~~/tl + [H+lf(, + K,I[H+l) (6) 
with (k~~~/~~)~,*~~ presenting the theoretical limiting value 
of k,,,/&, the best fit corresponded to the groups with 
pK, values of (4.4 & 0.1) and (7.8 ? 0.1). These are in 
excellent agreement with those obtained with recombi- 
nant human cathepsin S [32]. 
4. D&us&on 
From the data obtained, it is evident that stefin B is 
a reversible, tight-binding inhibitor of cathepsin S 
(K, = 8.0 PM). In addition, stefin B is also a very fast 
acting inhibitor of cathepsin S. The association rate con- 
0 2 4 6 8 10 12 
Inhibitor concentration [pM] 
Fig. 2. Dependence of the pseudo-Fiat-order rate constant k from stefin 
B concentration for cathepsin S-stefin B interaction at 25°C and pH 
6.0, and at 20,uM Z-Phe-Arg-AMC. The solid line was calculated using 
linear regression analysis. Inset: substrate dependency of pseudo-first- 
order rate constant. The stefin B and cathepsin S concentrations were 
500 nM and 50 nM, respectively. 
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Fig. 3. pH-dependence of the second-order ate constant, k,,,, for the interaction between cathepsin S and stefin B (A) and pH activity profile for 
cathepsin S (B). Ail the measurements were performed at 25°C as described in section 2.The data were fitted to Eqn. 4 (A) or 5 (B). The solid lines 
are the theoretical curves corresponding to best fits. 
stant for their interaction is extremely high (6.1 x 10’ 
M-’ . SC’), but still comparable to the values obtained for 
some other CPI-cysteine proteinase interactions [9,24, 
25.33,34]. Brijmrne et al. [23] suggested the occurrence of 
a fast pre-equilibrium, which we could not confirm ex- 
perimentally. The linearity of increase of the pseudo- 
first-order rate constant for complex formation with in- 
creasing inhibitor concentration indicated lack of the fast 
pre-equilibrium step, which is consistent with the present 
knowledge about the cysteine proteinases and their inter- 
actions with the cystatin-like inhibitors [9,24,25]. It is 
also in agreement with the crystal structure of stefin 
B-papain complex [lo] and the docking experiments for 
the interaction based on the crystal structure of chicken 
cystatin [ 121, where it has been shown that only negligible 
conformational changes are accompanying the enzyme- 
inhibitor interaction. In addition, the competitive nature 
of inhibition was confirmed consistently with previous 
experiments on some other cystatins [9,11]. 
The effect of pH on the association rate was investi- 
gated between pH 3.5 and 8.5. The lack of inhibition at 
pH 3.5 was caused by the instability of stefin B under the 
experimental conditions (ierovnik, E., unpublished re- 
sults). At higher pH values a bell-shaped pH-dependence 
of stefin Bxathepsin S interaction was observed with at 
least two ionizable groups involved in the interaction, 
consistently with the interaction between papain and 
chicken cystatin [24]. Similarly a bell-shaped curve was 
observed also for substrate hydrolysis, but with different 
ionizable groups involved. This results indicate, that the 
inhibitor binding is controlled by different ionizable 
groups of the enzyme than is the substrate hydrolysis, 
although we can not completely exclude the involvement 
of ionizable groups that can affect the conformation of 
stefin B. 
Under normal conditions lysosomal cysteine pro- 
teinases are known to act mainly intracellularly [35]. 
However, in several disease states they have also been 
detected extracellularly in significant amounts [36]. A 
strict control of their action is therefore needed also to 
prevent this harmful extracellular proteolysis. This may 
be particularly important in the case of cathepsin S, 
which differs from other lysosomal papain-like enzymes 
by its remarkably enhanced pH-stability under neutral 
conditions [20]. On the other hand, the binding of stefin 
B to cathepsin S was found to be unaffected around 
neutral pH, which is of great physiological importance. 
In addition, stefin B is known to be generally distributed 
amongst different cell types [2] and it has been detected 
also in different fluids in concentrations which are not 
insignificant [34]. According to Bieth [37] and our kinetic 
data we might assume, that stefin B-induced inhibition 
of cathepsin S in vivo is pseudo-irreversible (k,,,[I,] 
>> kdlss). This is even more true for the total CPIs-in- 
duced inhibition where we should take in account besides 
stefin B also the large inhibitory potential of cystatin C 
and kininogens [33,34]. Therefore we might conclude 
that the inhibitory pathway is much more important in 
the regulation of cathepsin S activity than its spontane- 
ous pH-induced inactivation, and that also stefin B is 
involved in this process. 
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